Protagenic Therapeutics's total assets for Q3 2025 were $2.14M, a decrease of 0.00% from the previous quarter. PTIX total liabilities were $9.70M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.